Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
33.3%
% of PJP's 30 holdings also in MEDX
33.3%
% of MEDX's 30 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 5.4% | 16.4% | 5.4% |
|
ABBVIE INC | 5.0% | 8.2% | 5.0% |
|
BRISTOL-MYERS SQUIBB CO | 4.9% | 6.1% | 4.9% |
|
AMGEN INC | 4.7% | 5.6% | 4.7% |
|
JOHNSON & JOHNSON | 4.8% | 4.6% | 4.6% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to MEDX
|
ABBOTT LABORATORIES | 4.9% |
|
TARSUS PHARMACEUTICALS, INC. | 3.1% |
|
GILEAD SCIENCES INC | 2.8% |
|
SUPERNUS PHARMACEUTICALS INC | 2.8% |
 |
JAZZ PHARMACEUTICALS PLC | 2.8% |
|
UNITED THERAPEUTICS CORP | 2.8% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 2.7% |
|
PRESTIGE BRANDS HOLDINGS INC | 2.7% |
|
LIQUIDIA TECHNOLOGIES, INC. | 2.7% |
|
LIGAND PHARMACEUTICALS-CL B | 2.7% |
PJP Underweight Relative to MEDX
|
ELI LILLY & CO | -11.0% |
 |
NOVARTIS AG-ADR | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.1% |
|
ALNYLAM PHARMACEUTICALS INC | -4.4% |
|
ALKERMES PLC | -4.3% |
|
ABBVIE INC | -3.2% |
|
CRISPR THERAPEUTICS AG | -2.9% |
|
IONIS PHARMACEUTICALS, INC. | -2.8% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.4% |
|
BEAM THERAPEUTICS, INC. | -1.7% |